Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2013
11/14/2013WO2012061557A3 Chemical compounds
11/14/2013US20130303772 Crystalline s-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
11/14/2013US20130303761 Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction
11/14/2013US20130303571 New compounds
11/14/2013US20130303567 Small molecule inhibitors of parp activity
11/14/2013US20130303542 Substituted pyrazinamide compounds for inflammation and immune-related uses
11/14/2013US20130303538 4-Tolyl-ethynyl-octahydro-indole-1-ester derivatives
11/14/2013US20130303537 1,2,3,4-tetrahydroquinoxaline compounds having glucocorticoid receptor binding activity
11/14/2013US20130303526 Pyridine Compounds and the Uses Thereof
11/14/2013US20130303525 Kappa opioid receptor agonists
11/14/2013US20130303522 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
11/14/2013US20130303517 Quinoxalines and aza-quinoxalines as crth2 receptor modulators
11/14/2013US20130303516 Novel triazine compounds
11/14/2013US20130303510 Nampt inhibitors
11/14/2013US20130303507 Substituted hetero-biaryl compounds and their uses
11/14/2013US20130303506 Amino-derivatives as novel inhibitors of histone deacetylase
11/14/2013US20130303505 Tgr5 agonists
11/14/2013US20130303493 Triazole Compounds that Modulate HSP90 Activity
11/14/2013US20130303492 3,5-diaminopyrazole kinase inhibitors
11/14/2013US20130303491 Antiviral Drugs for Treatement or Prevention of Dengue Infection
11/14/2013US20130302378 Matrix metalloproteinase inhibitors
11/13/2013EP2662367A1 Novel indole or indazole derivative or salt thereof
11/13/2013EP2662366A1 Novel triazinedione derivatives as GABA-B receptor modulators
11/13/2013EP2662357A1 Novel bicyclic compound or salt thereof
11/13/2013EP2662356A1 Condensed-cyclic compound and organic light emitting diode having organic layer including the same
11/13/2013EP2661433A1 Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd)
11/13/2013EP2661432A1 Pyrrolidine derivatives as nk3 antagonists
11/13/2013EP2661431A2 Heterocyclic compounds for the inhibition of pask
11/13/2013EP2661425A2 Hedgehog antagonists having zinc binding moieties
11/13/2013EP2661424A1 Chemical compounds
11/13/2013EP2661265A1 Quinolines and aza-quinolines as crth2 receptor modulators
11/13/2013CN103391935A Diaminopyrimidine derivatives and processes for the preparation thereof
11/13/2013CN103391934A Dipyridylamine derivative
11/13/2013CN103391933A Compounds having bipyridyl group and carbazole ring, and organic electroluminescent element
11/13/2013CN103391932A Heterocyclic compounds for the inhibition of pask
11/13/2013CN103391931A A method of treating liver fibrosis
11/13/2013CN103391924A Novel antiviral compounds
11/13/2013CN103387830A Chromium-ion ratio type fluorescence probe as well as preparation method and application thereof
11/13/2013CN103387569A Antineoplastic compounds, preparation method thereof and applications thereof
11/13/2013CN103387568A Compounds, preparation method thereof and applications thereof
11/13/2013CN103387567A NEPT compound and preparation method and application thereof
11/13/2013CN103387566A Preparation method of 3-[[[2-[[4-cyanophenyl) amino] methyl]-1-methyl-1H-benzimidazole-5-yl] carbonyl] (pyridine-2-yl) amino] ethyl propionate
11/13/2013CN103387565A Preparation method of Axitinib
11/13/2013CN103387564A Phenols electrochemical sensor based on ionic liquid-graphene oxide sensitive membrane
11/13/2013CN103387535A Substituted alkynylpyridine compound, and application method and use thereof
11/13/2013CN102617550B Method for treating imazapyr-containing herbicide mother liquor
11/13/2013CN102219796B Coordination polymer with selective ion exchange property, and applications thereof
11/13/2013CN102105448B Phenoxypyridinylamide derivatives and use thereof in the treatment of PDE4 mediated disease states
11/13/2013CN101883764B Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases
11/13/2013CN101801951B 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-[1, 4'] bipyridinyl-2'-ones
11/13/2013CN101687844B Imidazole derivatives as CCR2 receptor antagonists
11/13/2013CN101679279B Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
11/13/2013CN101568531B Polymorphs of a mglur5 receptor antagonist
11/13/2013CN101481517B Preparation of cotton fibre yellow reactive dye
11/13/2013CA2833209A1 Trpv1 antagonists and uses thereof
11/12/2013US8580965 Substituted sulfonamide compounds
11/12/2013US8580961 2-phenyl-6-azolylpyridine-based ligand and group VIII transition metal complex
11/12/2013US8580959 Azolotriazinone melanin concentrating hormone receptor-1 antagonists
11/12/2013US8580957 Thetrahydroquinolines derivatives as bromodomain inhibitors
11/12/2013US8580838 5-membered heterocycle-based p38 kinase inhibitors
11/12/2013US8580834 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
11/12/2013US8580820 Tubulysin compounds with high cytotoxicity, pharmaceutical compositions thereof, and method of use thereof
11/12/2013US8580817 1-(1-OXO-1,2,3,4-tetrahydroisoquinolin-7-YL)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
11/12/2013US8580806 Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
11/12/2013US8580804 Compound having hetero ring skeleton, and process for producing optically active compound using the aforementioned compound as asymmetric catalyst
11/12/2013US8580798 Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders
11/12/2013US8580796 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
11/12/2013US8580794 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/12/2013US8580786 Triazine derivatives and their therapeutical applications
11/12/2013US8580785 Insecticides
11/12/2013US8580781 Pyridazinone derivatives
11/12/2013US8580780 6 substituted 2, 3,4,5 tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonist
11/12/2013US8580773 Small-molecule inhibitors of the androgen receptor
11/12/2013US8580398 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
11/12/2013US8580391 Material for organic electroluminescence devices and organic electroluminescence device using the material
11/12/2013CA2675419C Heterocyclic-substituted piperidine compounds and the uses thereof
11/12/2013CA2623822C 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors
11/12/2013CA2615669C Salts of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
11/12/2013CA2607917C Fungicide 2-pyridyl-methylene-carboxamide derivatives
11/12/2013CA2606683C 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
11/07/2013WO2013165192A1 Novel organic electroluminescence compounds and organic electroluminescence device containing the same
11/07/2013WO2013164773A1 Substituted pyrazole compounds as crac modulators
11/07/2013WO2013164337A1 New compounds and new use
11/07/2013WO2013164245A1 Plant growth regulating compounds
11/07/2013US20130296551 7-membered ring compound and method of production and pharmaceutical application thereof
11/07/2013US20130296389 Fungicide Active Substance Combinations
11/07/2013US20130296382 Non-nucleoside reverse transcriptase inhibitors
11/07/2013US20130296378 Triazole compounds that modulate hsp90 activity
11/07/2013US20130296377 Complement pathway modulators and uses thereof
11/07/2013US20130296376 One pot process for the preparation of benzimidazole derivatives
11/07/2013US20130296363 Quinoline and isoquinoline derivatives for use as jak modulators
11/07/2013US20130296357 Methods of using alk inhibitors
11/07/2013US20130296355 Glucagon receptor modulators
11/07/2013US20130296333 Hedgehog pathway modulators
11/07/2013US20130296332 1h-quinazoline-2,4-diones
11/07/2013US20130296327 Substituted heterocylic compounds
11/07/2013US20130296320 Novel bicyclic compound or salt thereof
11/07/2013US20130296318 Compounds and compositions as protein kinase inhibitors
11/07/2013US20130296309 Aryl pyridine as aldosterone synthase inhibitors
11/07/2013US20130296300 Quinolines and aza-quinolines as crth2 receptor modulators
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 1080